In-Bore MRI-guided Prostate Biopsies in Patients with Prior Positive Transrectal US-guided Biopsy Results: Pathologic Outcomes and Predictors of Missed Cancers.
Kareem K ElfatairyChristopher P FilsonMartin G SandaAdeboye O OsunkoyaSherif G NourPublished in: Radiology. Imaging cancer (2020)
Performing confirmatory in-bore MRI-guided biopsy following positive transrectal US-guided biopsy resulted in a high disease-upgrade incidence with subsequently improved disease-risk stratification, particularly when considering patients for active surveillance or focal therapy. Supplemental material is available for this article. © RSNA, 2020See also the commentary by Weiss and Solomon in this issue.
Keyphrases
- ultrasound guided
- end stage renal disease
- magnetic resonance imaging
- fine needle aspiration
- prostate cancer
- newly diagnosed
- ejection fraction
- chronic kidney disease
- type diabetes
- stem cells
- neoadjuvant chemotherapy
- prognostic factors
- squamous cell carcinoma
- peritoneal dialysis
- computed tomography
- metabolic syndrome
- insulin resistance
- lymph node
- smoking cessation
- patient reported
- replacement therapy